Human Cytomegalovirus Antigen Presentation by HLA ‐G in Infected Cells
HLA · 2025
DOI: 10.1111/tan.70089 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2025. Verfasst von Mireia Altadill und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Life Sciences, University Pompeu Fabra, Barcelona, Spain. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Cytomegalovirus, Antigen Presentation, HLA-G Antigens. Die Arbeit nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Estatal de Investigación, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
HLA‐E and ‐G class Ib molecules were considered unrelated to viral antigen presentation. HLA‐E binds nonamers from the leader sequences of other HLA‐I molecules and the human cytomegalovirus (HCMV) UL40 protein, interacting with CD94/NKG2 NK cell receptors. Yet, evidence that HLA‐E may present some pathogen‐derived peptides to CD8+ T lymphocytes has been reported. By contrast, HLA‐G binds a broad spectrum of endogenous sequences but its role in antigen presentation is unknown. An experimental approach was set up to search for HCMV antigens displayed by HLA‐G in infected cells. Among the analysed peptidome, 22 sequences corresponding to 16 HCMV molecules were identified; 17 peptides were confirmed to interact in vitro with HLA‐G of which 10 displayed characteristic anchor residues. As compared to the response in short‐term (6 h) assays to immunodominant IE‐1 and pp65 antigens, none of the HLA‐G‐binding peptides stimulated cytokine production by CD8+ T cells from HCMV‐seropositive blood donors ( n = 15). Following a 14‐day peptide stimulation of PBMC and expansion with IL‐2, CD8+ T cells specifically responding to a subset of these viral antigens were detected in some individuals, yet were not restricted by HLA‐G in functional assays. A subset of viral peptides did bind to both HLA‐G and ‐E but were not recognised by CD94/NKG2 NK cell receptors. Our results provide the first evidence that HLA‐G may display potentially immunogenic viral peptides in HCMV‐infected cells, yet do not support their ability to promote HLA‐G‐restricted CD8+ T cell responses nor to modulate NK cell functions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine and Life Sciences, University Pompeu Fabra, Barcelona, Spain.
- Department of Cell Biology, Physiology and Immunology, Institute of Biotechnology and Biomedicine, Autonomous University of Barcelona, Bellaterra, Spain.
- Hospital del Mar Research Institute, Barcelona, Spain.
- Biological Sciences Department, The University of Texas at El Paso, El Paso, USA.
- Institute of Virology, Medical Center University of Freiburg, Freiburg, Germany.
- Faculty of Medicine, University of Freiburg, Freiburg, Germany.
ORCID-Profile: Miguel López-Botet
Förderung
- Agencia Estatal de Investigación
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Altadill, M., Álvarez, I., Ataya, M., Heredia, G., Alari-Pahissa, E., Muntasell, A., Llano, M., Fuchs, J., Vilches, C., Hengel, H., Halenius, A., & López-Botet, M. (2025). Human Cytomegalovirus Antigen Presentation by HLA ‐G in Infected Cells. HLA. https://doi.org/10.1111/tan.70089
Vancouver
Altadill M, Álvarez I, Ataya M, Heredia G, Alari-Pahissa E, Muntasell A, et al. Human Cytomegalovirus Antigen Presentation by HLA ‐G in Infected Cells. HLA. 2025. doi:10.1111/tan.70089
BibTeX
@article{Altadill2025,
author = {Altadill, Mireia and Álvarez, Iñaki and Ataya, Michelle and Heredia, Gemma and Alari-Pahissa, Elisenda and Muntasell, Aura and Llano, Manuel and Fuchs, Jonas and Vilches, Carlos and Hengel, Hartmut and Halenius, Anne and López-Botet, Miguel},
title = {Human Cytomegalovirus Antigen Presentation by HLA ‐G in Infected Cells},
journal = {HLA},
year = {2025},
doi = {10.1111/tan.70089}
}
EUVIMED